Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q3

Therapeutic Advances in Rare Disease

United KingdomInternal Medicine (Q3)ISSN-matched source record
Q3Ranking
—Impact Factor (year unverified)
11H-index (SCImago 2025)
0.503SJR (2025)
2020-2026Coverage

About Therapeutic Advances in Rare Disease

Therapeutic Advances in Rare Disease is a scholarly journal published by SAGE Publications Ltd. SCImago 2025 lists it in Q3, with an SJR of 0.503 and H-index of 11.

Coverage: 2020-2026. Research categories: Internal Medicine (Q3).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-04. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC
Peer-review processAnonymous peer review
APCNo APC reported in the DOAJ snapshot
Waiver policy reportedNo
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS
Reported submission-to-publication time15 weeks on average; not a guarantee
Openly licensed content since2020 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2633-0040
ISSN-L2633-0040
Source typeJournal
Publisher / hosting organisationSAGE Publishing
Publisher country codeGB
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex143
Citations recorded in OpenAlex725
OpenAlex H-index14
Years represented in OpenAlex2020–2026 (not the founding or closing dates)

Topics in published research

Genomics and Rare Diseases; Lysosomal Storage Disorders Research; Mitochondrial Function and Pathology; Genetics and Neurodevelopmental Disorders; Health Systems, Economic Evaluations, Quality of Life; Glycogen Storage Diseases and Myoclonus.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-01. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit